Hereditary poikiloderma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:222628
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary poikiloderma (Orphanet code 222628) is a group of rare inherited skin disorders characterized by poikiloderma, a distinctive combination of skin changes that includes reticulated (net-like) hypo- and hyperpigmentation, skin atrophy, and telangiectasia (small dilated blood vessels). These changes typically develop in early life and primarily affect the skin, though associated features may vary depending on the specific subtype. The term 'hereditary poikiloderma' serves as a broad grouping category that encompasses several distinct genetic conditions sharing the hallmark poikilodermatous skin findings. The skin manifestations usually begin in infancy or childhood and may be photosensitive, worsening with sun exposure. Depending on the specific underlying condition, patients may also experience skeletal abnormalities, short stature, sparse hair, nail dystrophy, cataracts, or an increased susceptibility to certain cancers. The most well-known conditions within this spectrum include Rothmund-Thomson syndrome, Kindler syndrome, and other hereditary poikiloderma subtypes, each with distinct genetic causes and associated systemic features. There is currently no cure for hereditary poikiloderma. Management is primarily supportive and symptomatic, focusing on strict sun protection, dermatologic surveillance, and monitoring for associated complications such as malignancies or skeletal problems. Genetic counseling is recommended for affected families. Regular follow-up with a multidisciplinary team including dermatologists, ophthalmologists, and oncologists may be warranted depending on the specific diagnosis within this disease group.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary poikiloderma.

View clinical trials →

No actively recruiting trials found for Hereditary poikiloderma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary poikiloderma community →

Specialists

1 foundView all specialists →
AM
Alexandra DJ Mancini, MSc
GREENACRES, FL
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary poikiloderma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary poikilodermaForum →

No community posts yet. Be the first to share your experience with Hereditary poikiloderma.

Start the conversation →

Latest news about Hereditary poikiloderma

No recent news articles for Hereditary poikiloderma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary poikiloderma

What is Hereditary poikiloderma?

Hereditary poikiloderma (Orphanet code 222628) is a group of rare inherited skin disorders characterized by poikiloderma, a distinctive combination of skin changes that includes reticulated (net-like) hypo- and hyperpigmentation, skin atrophy, and telangiectasia (small dilated blood vessels). These changes typically develop in early life and primarily affect the skin, though associated features may vary depending on the specific subtype. The term 'hereditary poikiloderma' serves as a broad grouping category that encompasses several distinct genetic conditions sharing the hallmark poikilodermat

At what age does Hereditary poikiloderma typically begin?

Typical onset of Hereditary poikiloderma is childhood. Age of onset can vary across affected individuals.

Which specialists treat Hereditary poikiloderma?

1 specialists and care centers treating Hereditary poikiloderma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.